HORMONE-DEPENDENT PROSTATE CANCER

HORMONE-DEPENDENT PROSTATE CANCER was reported 70 times

These drug classes are most commonly taken by patients reporting HORMONE-DEPENDENT PROSTATE CANCER:

# Drug Count
0 Microtubule Inhibitor [EPC] 20
1 Androgen Receptor Inhibitor [EPC] 16
2 Angiotensin 2 Receptor Blocker [EPC] 10
3 Nonsteroidal Anti-inflammatory Drug [EPC] 10
4 Radioligand Therapeutic Agent [EPC] 10
5 alpha-Adrenergic Blocker [EPC] 10
6 beta-Adrenergic Blocker [EPC] 10
7 Aldosterone Antagonist [EPC] 9
8 Loop Diuretic [EPC] 9
9 Xanthine Oxidase Inhibitor [EPC] 9
10 Proton Pump Inhibitor [EPC] 7
11 Corticosteroid [EPC] 6
12 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5
13 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5
14 Radioactive Diagnostic Agent [EPC] 5
15 Calcium Channel Blocker [EPC] 2
16 Calcium [EPC] 2
17 Dihydropyridine Calcium Channel Blocker [EPC] 2
18 Leukocyte Growth Factor [EPC] 2
19 Programmed Death Receptor-1 Blocking Antibody [EPC] 2
20 Androgen [EPC] 1
21 Antimetabolite Immunosuppressant [EPC] 1
22 Arteriolar Vasodilator [EPC] 1
23 Chloride Channel Activator [EPC] 1
24 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
25 Factor Xa Inhibitor [EPC] 1
26 Fluoroquinolone Antibacterial [EPC] 1
27 Gonadotropin Releasing Hormone Receptor Antagonist [EPC] 1
28 Kinase Inhibitor [EPC] 1
29 Non-Standardized Chemical Allergen [EPC] 1
30 Non-Standardized Food Allergenic Extract [EPC] 1
31 Non-Standardized Plant Allergenic Extract [EPC] 1
32 Phenothiazine [EPC] 1
33 Phosphodiesterase 5 Inhibitor [EPC] 1
34 Platelet Aggregation Inhibitor [EPC] 1
35 Provitamin D2 Compound [EPC] 1
36 RANK Ligand Inhibitor [EPC] 1
37 Serotonin-3 Receptor Antagonist [EPC] 1
38 alpha-Glucosidase Inhibitor [EPC] 1